Immunological properties of hepatitis B core antigen fusion proteins.
AUTOR(ES)
Francis, M J
RESUMO
The immunogenicity of a 19 amino acid peptide from foot-and-mouth disease virus has previously been shown to approach that of the inactivated virus from which it was derived after multimeric particulate presentation as an N-terminal fusion with hepatitis B core antigen. In this report we demonstrate that rhinovirus peptide-hepatitis B core antigen fusion proteins are 10-fold more immunogenic than peptide coupled to keyhole limpet hemocyanin and 100-fold more immunogenic than uncoupled peptide with an added helper T-cell epitope. The fusion proteins can be readily administered without adjuvant or with adjuvants acceptable for human and veterinary application and can elicit a response after nasal or oral dosing. The fusion proteins can also act as T-cell-independent antigens. These properties provide further support for their suitability as presentation systems for "foreign" epitopes in the development of vaccines.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=53726Documentos Relacionados
- Phosphorylation of hepatitis B virus precore and core proteins.
- Distinctive properties of the hepatitis B virus envelope proteins.
- Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.
- Stability of the recombinant hepatitis B core antigen.
- Non-immunological precipitation of protein-DNA complexes using glutathione-S-transferase fusion proteins.
